Hims & Hers Health (HIMS) Insider Trading & Ownership $16.43 +0.13 (+0.80%) (As of 12:58 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Hims & Hers Health (NYSE:HIMS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.71%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.95 MNumber OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$35.12 M HIMS Insider Buying and Selling by Quarter Ad Investors AlleyThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thing that can't be stopped by anything: Dividends.Download my Dividend Calendar here Hims & Hers Health Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/17/2024Soleil BoughtonInsiderSell2,339$16.50$38,593.50 9/4/2024Melissa BairdCOOSell11,749$14.65$172,122.85 9/3/2024Andrew DudumCEOSell188,888$14.56$2,750,209.28 9/3/2024Oluyemi OkupeCFOSell11,609$14.60$169,491.40 9/3/2024Soleil BoughtonInsiderSell2,345$14.65$34,354.25 8/27/2024Christiane PendarvisDirectorSell7,000$15.15$106,050.00 The election trade you can't lose (Ad)Politics is an unpredictable game. But no matter what happens in the next few months... There's one thing that can't be stopped by anything: Dividends.Download my Dividend Calendar here8/16/2024Irene BecklundInsiderSell472$15.66$7,391.52 8/6/2024Melissa BairdCOOSell16,784$17.00$285,328.00 8/6/2024Soleil BoughtonInsiderSell2,334$17.30$40,378.20 8/5/2024Andrew DudumCEOSell188,888$16.47$3,110,985.36 8/1/2024Michael ChiInsiderSell2,054$22.00$45,188.00 7/23/2024Soleil BoughtonInsiderSell2,335$20.29$47,377.15 7/16/2024Irene BecklundInsiderSell472$23.23$10,964.56 7/12/2024Michael ChiInsiderSell9,313$22.00$204,886.00 7/9/2024Melissa BairdCOOSell17,625$20.42$359,902.50 7/9/2024Soleil BoughtonInsiderSell2,335$20.28$47,353.80 7/5/2024Melissa BairdCOOSell17,625$20.51$361,488.75 7/3/2024Andrew DudumCEOSell188,888$20.75$3,919,426.00 6/25/2024Oluyemi OkupeCFOSell11,546$22.21$256,436.66 6/24/2024Michael ChiInsiderSell17,303$22.07$381,877.21 6/20/2024Andrew DudumCEOSell45,755$22.97$1,050,992.35 6/20/2024Michael ChiInsiderSell7,500$24.50$183,750.00 6/17/2024Irene BecklundInsiderSell472$24.10$11,375.20 6/6/2024Oluyemi OkupeCFOSell98,635$21.42$2,112,761.70 6/4/2024Andrew DudumCEOSell188,888$19.88$3,755,093.44 6/4/2024Melissa BairdCOOSell17,625$20.42$359,902.50 5/30/2024Soleil BoughtonInsiderSell129,667$20.55$2,664,656.85 5/28/2024Soleil BoughtonInsiderSell2,502$17.33$43,359.66 5/22/2024Christopher D PayneDirectorBuy110,000$17.74$1,951,763.00 5/20/2024Soleil BoughtonInsiderSell4,915$20.01$98,349.15 5/17/2024Irene BecklundinsiderSell943$14.50$13,673.50 5/13/2024Christiane PendarvisDirectorSell4,000$12.33$49,320.00 5/13/2024Soleil BoughtonInsiderSell2,503$12.33$30,861.99 5/9/2024Patrick Harrison CarrollInsiderSell10,000$13.00$130,000.00 5/2/2024Melissa BairdCOOSell11,750$12.08$141,940.00 5/1/2024Andrew DudumCEOSell188,888$12.54$2,368,655.52 4/29/2024Soleil BoughtonInsiderSell2,503$12.56$31,437.68 4/15/2024Soleil BoughtonInsiderSell2,503$13.95$34,916.85 4/8/2024Melissa BairdCOOSell11,751$14.74$173,209.74 4/5/2024Melissa BairdCOOSell11,751$14.58$171,329.58 Forget Trump and Kamala (Ad)I hope you're deleting all those emails telling you how to make "1,000% gains" from the magic "Kamala Trade". It's nonsense. No one knows what's going to happen in November.THIS CALENDAR is the only thing that matters for you and your financial health right now.4/4/2024Andrew DudumCEOSell188,888$14.97$2,827,653.36 4/1/2024Soleil BoughtonInsiderSell2,503$15.65$39,171.95 3/20/2024Andrew DudumCEOSell50,361$16.34$822,898.74 3/20/2024Oluyemi OkupeCFOSell9,912$15.82$156,807.84 3/19/2024Lynne Chou O'keefeDirectorSell10,044$15.52$155,882.88 3/18/2024Irene BecklundInsiderSell472$14.70$6,938.40 3/13/2024Soleil BoughtonInsiderSell63,621$15.17$965,130.57 3/7/2024Irene BecklundInsiderSell2,747$14.19$38,979.93 3/6/2024Melissa BairdCOOSell11,751$13.99$164,396.49 2/27/2024Irene BecklundInsiderSell2,747$12.08$33,183.76 2/13/2024Andrew DudumCEOSell97,208$9.58$931,252.64 2/12/2024Oluyemi OkupeCFOSell31,363$10.03$314,570.89 2/12/2024Soleil BoughtonInsiderSell22,839$10.03$229,075.17 2/9/2024Oluyemi OkupeCFOSell8,509$10.03$85,345.27 2/9/2024Soleil BoughtonInsiderSell4,080$10.03$40,922.40 1/29/2024Andrew DudumCEOSell15,100$9.01$136,051.00 1/25/2024Andrew DudumCEOSell127,688$9.08$1,159,407.04 1/2/2024Soleil BoughtonInsiderSell13,744$8.80$120,947.20 12/29/2023Andrew DudumCEOSell21,432$9.06$194,173.92 12/27/2023Andrew DudumCEOSell7,700$9.02$69,454.00 12/20/2023Oluyemi OkupeCFOSell6,784$8.58$58,206.72 12/19/2023Irene BecklundInsiderSell10,597$8.73$92,511.81 12/19/2023Lynne Chou O'keefeDirectorSell10,045$8.73$87,692.85 12/6/2023Melissa BairdCOOSell9,133$9.02$82,379.66 12/4/2023Melissa BairdCOOSell9,133$8.81$80,461.73 12/1/2023Andrew DudumCEOSell24,300$9.03$219,429.00 11/21/2023Oluyemi OkupeCFOSell6,698$7.62$51,038.76 11/7/2023Melissa BairdCOOSell9,133$7.07$64,570.31 10/5/2023Melissa BairdCOOSell9,133$6.23$56,898.59 10/3/2023Melissa BairdCOOSell9,133$6.32$57,720.56 (Data available from 1/1/2013 forward) HIMS Insider Trading Activity - Frequently Asked Questions Who is on Hims & Hers Health's Insider Roster? The list of insiders at Hims & Hers Health includes Alex Bard, Andrew Dudum, Christiane Pendarvis, Christopher D Payne, David B Wells, Irene Becklund, Jack Abraham, Jules A Maltz, Lynne Chou O'keefe, Melissa Baird, Michael Chi, Oluyemi Okupe, Patrick Harrison Carroll, and Soleil Boughton. Learn more on insiders at HIMS. What percentage of Hims & Hers Health stock is owned by insiders? 17.71% of Hims & Hers Health stock is owned by insiders. Learn more on HIMS's insider holdings. Which Hims & Hers Health insiders have been buying company stock? The following insider purchased HIMS shares in the last 24 months: Christopher D Payne ($1,951,763.00). How much insider buying is happening at Hims & Hers Health? Insiders have purchased a total of 110,000 HIMS shares in the last 24 months for a total of $1,951,763.00 bought. Which Hims & Hers Health insiders have been selling company stock? The following insiders have sold HIMS shares in the last 24 months: Alex Bard ($5,775,000.00), Andrew Dudum ($24,478,598.94), Christiane Pendarvis ($155,370.00), David B Wells ($977,000.00), Irene Becklund ($609,172.17), Lynne Chou O'keefe ($701,553.56), Melissa Baird ($4,030,529.66), Michael Chi ($815,701.21), Oluyemi Okupe ($3,448,046.12), Patrick Harrison Carroll ($130,000.00), and Soleil Boughton ($6,104,658.39). How much insider selling is happening at Hims & Hers Health? Insiders have sold a total of 3,472,822 Hims & Hers Health shares in the last 24 months for a total of $47,225,630.05 sold. More Insider Trading Tools from MarketBeat Related Companies: FMS Insider Trading PACS Insider Trading OPCH Insider Trading SHC Insider Trading SGRY Insider Trading GH Insider Trading LFST Insider Trading VCYT Insider Trading BTSG Insider Trading ADUS Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NYSE:HIMS) was last updated on 9/23/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredElon’s solution (some don’t like it)One company holds a near-total monopoly on this technology. Elon Musk is one of the few people who knows th...Porter & Company | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredYou are NOT going to believe this!Is this new “SUPER AI” better than ChatGPT? This Thursday, September 26th at 2pm ET / 11am PT Dan Holling ...AI Profit Pathways | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Hims & Hers Health, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.